Lacidipine

拉西地平

Report date: 2026/03/23 20:03:44
NME

Base Information

Drug NameLacidipine
Drug Alias Namelacidipinum乐息地平lacidipinelacidipinoViapres +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsHypertensionAngina Pectoris
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryItaly
Original Approved Date1991/01/01
Country/TerritoryItalyMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline IncHarbin Pharmaceutical Group Sanjingmingshui Pharmaceutical Co Ltd
Inactive CompaniesC.H. Boehringer Sohn Ag & Co. Kg
Active IndicationsHypertension
Inactive IndicationsAngina Pectoris

Other Information

ATC CodeC08CA09
Related LinksWikipediaDrugBankKEGG